Experts: Pharmacy benefit companies can drive up drug prices

 
LOADING
Nov 09, 2005 - 02:02:00 CST
Many companies that manage employee prescription drug benefit plans overcharge businesses for drugs, and may be responsible for escalating prices, say experts who advocate greater industry regulation and disclosure.

Pharmacy benefit managers have "enabled (drug) manufacturers to raise their prices more rapidly, and higher," said Gary Gustafson, an account manager for ClearScript, a pharmacy benefit manager that is part of Fairview Health Services of Minneapolis.

ClearScript is more open in its operations than the industry's biggest companies, Gustafson told members of the North Dakota Legislature's interim Industry, Business and Labor Committee on Tuesday.

"I think the (pharmacy benefit management) industry has done a lot to increase the cost of drugs, and I challenge the PBM industry to say that isn't true," he said.

Spokesmen for Medco Health Solutions Inc. of Franklin Lakes, N.J., and Caremark Rx Inc. of Nashville, Tenn., said additional state regulation of the industry is not needed. Medco, Caremark and Express Scripts Inc. of Maryland Heights, Mo., are the nation's three largest pharmacy benefit managers.

A Federal Trade Commission report in September and a separate federal Government Accountability Office report published in January 2003 concluded that pharmacy benefit managers provide less expensive drugs to beneficiaries, said Peter Harty, a Medco vice president. The industry also has more than 50 companies, he said.

"Do you need more law? Do you need more regulation? The answer, from our point of view, is clearly 'No,'" Harty said. "The marketplace is working. We're saving money for employees, for employers, for health plans, and the marketplace has addressed the issues that need to be addressed."

Harty and Allen Horne, a Caremark Rx vice president, said forced disclosure of managers' rebate agreements with drug companies would prompt them to offer smaller discounts, which would mean costlier drugs for customers.

Harty said no other industry is required to disclose similar financial information, and compared the suggestion to requiring car dealers to openly post the details of every sale.

"If everybody knows the deal that the best PBM out there gets, those deals are going to dry up," he said.

Pushed by North Dakota pharmacists, the Legislature approved a new law this year requiring the state Insurance Department to license pharmacy benefit managers. It gives the department authority to audit PBM contracts.

The law also requested an interim legislative study of pharmacy benefit managers' operations, which the Industry, Business and Labor Committee will be doing over the next year.

Pharmacists had wanted a stronger measure, which would have required PBMs to disclose audits of their operations, and terms of their rebate agreements with drug manufacturers. Patricia Hill, director of the North Dakota Pharmacists Association, said it was patterned after a law the South Dakota Legislature approved last year.

Harty said companies that hire pharmacy benefit managers negotiate contracts with them, and can insist on as much disclosure as they please while the contract is being drawn.
   Printer friendly version
Experts: Pharmacy benefit companies can drive up drug prices
Comments
Post Your Own Comment
(optional)
   
All online comments are limited to 350 words total.
Comments are reviewed for taste, tone and language before posting.
Some comments may be used in the Tribune's print edition.
We value and respect your privacy, but The Bismarck Tribune might
disclose certain information to governmental entities if served with subpoena.

Copyright © 2009 Bismarck Tribune, a division of Lee Enterprises.  -PRIVACY POLICY